XOMA Royalty Corp.

XOMA Corporation is an innovative biotechnology company that specializes in the discovery, development, and licensing of antibody therapeutics. The primary aim of the company is to license its drug candidates and proprietary platform to other pharmaceutical companies, thereby harnessing its expertise in antibody engineering. This enables partnership opportunities that advance therapeutic solutions through various stages of clinical trials without the direct burden of commercialization. XOMA focuses heavily on the fields of oncology and immunology, impacting how diseases in these sectors are approached and treated. The company is significant in the biotechnology market as it provides critical resources and innovations that fuel the development pipeline of larger pharmaceutical enterprises. Based in Emeryville, California, XOMA leverages its comprehensive portfolio of antibody-based therapeutics to play a pivotal role in advancing the medical and health industries through collaborations and strategic partnerships.